December 27, 2018
Nichi-Iko Pharmaceutical and Towa Pharmaceutical said on December 26 that their generic versions of the cholesterol fighter Crestor (rosuvastatin) have obtained approval for familial hypercholesterolemia. With the latest nods, the two companies’ generics now have the full indications carried by...read more